Literature DB >> 9850488

Relation of glycemic control to diabetic complications and health outcomes.

R Klein1, B E Klein.   

Abstract

Data from the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) demonstrated that the incidence of diabetic complications is directly related to glycemic control. The results of the Diabetes Control and Complications Trial and Stockholm Study showed that intensive insulin therapy and improved glycemic control reduced diabetic complications in people with type 1 diabetes. Results of the U.K. Prospective Diabetes Study Group and the Kumamoto trial also support the relationship between glycemic control and diabetic complications in individuals with type 2 diabetes. Preliminary WESDR health outcomes data suggest that higher levels of glycemia are related to a decreasing quality of life. This study and others showing that higher levels of glycemia are associated with an increased incidence of complications suggest that it is the complications of diabetes that contribute to a decrease in quality of life. Despite evidence of the benefits of improved glycemic control, a large percentage of people with diabetes maintain poor glucose control in part because of the limitations of the therapies available for diabetes management.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850488     DOI: 10.2337/diacare.21.3.c39

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

1.  Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study.

Authors:  Kashif Mazhar; Rohit Varma; Farzana Choudhury; Roberta McKean-Cowdin; Corina J Shtir; Stanley P Azen
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

2.  [Comparison of risk factors and guideline oriented prevention and therapy of diabetic retinopathy between type 2 diabetes patients undergoing laser therapy and type 2 diabetes outpatients].

Authors:  Ralf Paschke; Florian Gerhard Wuthe; Katja Kühn; Claudia Jochmann; Peter Wiedemann
Journal:  Med Klin (Munich)       Date:  2010-12-07

3.  Change in perceived health and functioning over time in patients with type I diabetes mellitus.

Authors:  Huberta E Hart; William K Redekop; Henk J G Bilo; Marc Berg; Betty Meyboom-de Jong
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

4.  Glycaemic control and quality of life among ethnically diverse Malaysian diabetic patients.

Authors:  Aqil Mohammad Daher; Syed Ahmad H AlMashoor; Than Winn
Journal:  Qual Life Res       Date:  2014-10-29       Impact factor: 4.147

5.  Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes.

Authors:  Joseph Keawe'aimoku Kaholokula; Stephen N Haynes; Andrew Grandinetti; Healani K Chang
Journal:  J Behav Med       Date:  2003-10

6.  Ethnic disparities in health-related quality of life among older rural adults with diabetes.

Authors:  Sara A Quandt; Christopher N Graham; Ronny A Bell; Beverly M Snively; Shannon L Golden; Jeanette M Stafford; Thomas A Arcury
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

7.  A test of the reliability and validity of a diabetes specific quality of life scale in a Nigerian hospital.

Authors:  B A Kolawole; O Abodunde; R T Ikem; A K Fabiyi
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

8.  The influence of cardiovascular disease on quality of life in type 2 diabetics.

Authors:  C L de Visser; H J G Bilo; K H Groenier; W de Visser; B Jong Meyboom-de
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

Review 9.  Genetic susceptibility of diabetic retinopathy.

Authors:  Shrena Patel; Haoyu Chen; Nicholas H Tinkham; Kang Zhang
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

10.  Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice.

Authors:  M W Sleeman; K Garcia; R Liu; J D Murray; L Malinova; M Moncrieffe; G D Yancopoulos; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.